Pancoast tumor screening

Revision as of 16:40, 26 February 2018 by Mazia Fatima (talk | contribs)
Jump to navigation Jump to search


Pancoast tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancoast tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancoast tumor screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancoast tumor screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancoast tumor screening

CDC onPancoast tumor screening

Pancoast tumor screening in the news

Blogs on Pancoast tumor screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pancoast tumor screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

There is insufficient evidence to recommend routine screening for Pancoast tumor.

Screening

  • There is insufficient evidence to recommend routine screening for Pancoast tumor.
  • The current guidelines for screening of lung cancer that results in pancoast tumor is as follows:
    • In 2013, a clinical practice guideline by the U.S. Preventive Services Task Force (USPSTF) recommended screening for lung cancer among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).[1]
    • Clinical practice guidelines issued by the American College of Chest Physicians in 2013 recommend:[2] [3][4]
    • For smokers and former smokers who are age 55 to 74 and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years, it was suggest that annual screening with low dose computed tomography (LDCT) should be offered in settings that can deliver the comprehensive care provided to National Lung Screening Trial (NLST) participants.

References

  1. "http://www.uspreventiveservicestaskforce.org/uspstf13/lungcan/lungcanfinalrs.htm". Retrieved 31 December 2013. External link in |title= (help)
  2. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB (2013). "Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 143 (5 Suppl): e78S–92S. doi:10.1378/chest.12-2350. PMID 23649455. Summary in JournalWatch
  3. Midthun, David E. (2016). "Early detection of lung cancer". F1000Research. 5: 739. doi:10.12688/f1000research.7313.1. ISSN 2046-1402.
  4. Midthun, David E. (2011). "Screening for Lung Cancer". Clinics in Chest Medicine. 32 (4): 659–668. doi:10.1016/j.ccm.2011.08.014. ISSN 0272-5231.

Template:WH Template:WS